STOCK TITAN
  1. Home
  2. Sec-filings
  3. PSTV
  4. [8-K] PLUS THERAPEUTICS, Inc. Reports Material Event

[8-K] PLUS THERAPEUTICS, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock PSTV logo
Plus Therapeutics Inc

NASDAQ:PSTV

PSTV Rankings

#9629 Ranked by Market Cap
N/A Ranked by Dividends

PSTV Latest News

Jul 15, 2025
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases
Jul 10, 2025
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference
Jul 8, 2025
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Jun 30, 2025
Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Jun 26, 2025
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary

PSTV Latest SEC Filings

Jul 11, 2025
[PRE 14A] PLUS THERAPEUTICS, Inc. Preliminary Proxy Statement
Jun 25, 2025
[SCHEDULE 13G/A] PLUS THERAPEUTICS, Inc. SEC Filing
Jun 24, 2025
[EFFECT] PLUS THERAPEUTICS, Inc. SEC Filing
Jun 23, 2025
[RW] PLUS THERAPEUTICS, Inc. SEC Filing
Jun 23, 2025
[424B3] PLUS THERAPEUTICS, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)

PSTV Stock Data

17.90M
49.97M
17.36%
11.5%
2.38%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
AUSTIN